Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Aryl Hydrocarbon | 6 | 2015 | 48 | 2.320 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 35 | 0.640 |
Why?
|
| Calpain | 2 | 2006 | 35 | 0.550 |
Why?
|
| Neoplasm Invasiveness | 2 | 2015 | 251 | 0.530 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 219 | 0.470 |
Why?
|
| Cytochrome P-450 CYP1A1 | 3 | 2015 | 51 | 0.470 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 409 | 0.410 |
Why?
|
| Mammary Glands, Human | 1 | 2011 | 39 | 0.380 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 80 | 0.370 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 626 | 0.370 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1198 | 0.370 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 172 | 0.350 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1015 | 0.340 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 807 | 0.320 |
Why?
|
| Gene Expression | 1 | 2011 | 674 | 0.310 |
Why?
|
| Down-Regulation | 2 | 2006 | 435 | 0.300 |
Why?
|
| Calcium | 2 | 2006 | 480 | 0.280 |
Why?
|
| Pyrazines | 1 | 2006 | 24 | 0.280 |
Why?
|
| Anticarcinogenic Agents | 1 | 2006 | 65 | 0.270 |
Why?
|
| Cell Line, Tumor | 5 | 2015 | 2231 | 0.260 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 1502 | 0.250 |
Why?
|
| Environmental Exposure | 2 | 2015 | 216 | 0.220 |
Why?
|
| Cell Cycle | 3 | 2013 | 326 | 0.200 |
Why?
|
| Enzyme Induction | 2 | 2015 | 53 | 0.200 |
Why?
|
| Mice | 5 | 2015 | 5913 | 0.180 |
Why?
|
| Tumor Cells, Cultured | 2 | 2014 | 502 | 0.170 |
Why?
|
| Animals | 7 | 2015 | 15081 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 623 | 0.170 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1207 | 0.160 |
Why?
|
| Protein Transport | 2 | 2011 | 302 | 0.150 |
Why?
|
| Humans | 9 | 2015 | 37093 | 0.150 |
Why?
|
| Cell Nucleus | 2 | 2011 | 366 | 0.150 |
Why?
|
| Hazardous Substances | 1 | 2015 | 18 | 0.130 |
Why?
|
| Dactinomycin | 1 | 2015 | 11 | 0.130 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2015 | 21 | 0.130 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 42 | 0.130 |
Why?
|
| Epithelial Cells | 2 | 2011 | 384 | 0.120 |
Why?
|
| Disease Progression | 2 | 2015 | 601 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 120 | 0.110 |
Why?
|
| Kinetics | 1 | 2015 | 708 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 306 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2015 | 179 | 0.110 |
Why?
|
| RNA Interference | 1 | 2013 | 243 | 0.100 |
Why?
|
| Female | 4 | 2014 | 20969 | 0.100 |
Why?
|
| Clone Cells | 1 | 2011 | 47 | 0.100 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 47 | 0.100 |
Why?
|
| Cytosol | 1 | 2011 | 93 | 0.100 |
Why?
|
| Cell Movement | 2 | 2011 | 571 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 229 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 358 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2006 | 173 | 0.080 |
Why?
|
| Cell Line | 1 | 2011 | 1354 | 0.070 |
Why?
|
| Thiones | 1 | 2006 | 2 | 0.070 |
Why?
|
| Thiophenes | 1 | 2006 | 31 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 172 | 0.070 |
Why?
|
| Apoptosis | 1 | 2013 | 1398 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 252 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2006 | 444 | 0.060 |
Why?
|
| Neoplasms | 1 | 2015 | 1103 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 433 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 893 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 578 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 197 | 0.050 |
Why?
|
| Smad3 Protein | 1 | 2004 | 11 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2004 | 8 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 91 | 0.010 |
Why?
|
| Mesoderm | 1 | 2004 | 70 | 0.010 |
Why?
|
| Cadherins | 1 | 2004 | 90 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 148 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 93 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2004 | 212 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 174 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 163 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 213 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 689 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 928 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 539 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 517 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 1518 | 0.010 |
Why?
|